In vivo gene mutation assays are considered the most definitive for the evaluation of human health risks. Suggestions are provided here for the critical evaluation of the application of established in vivo gene mutation assays and alternative approaches in the evaluation of industrial chemicals. Obj
A perspective on measurement of mutations in vivo
β Scribed by Raymond W. Tennant
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 221 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0893-6692
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Patients with Alzheimer's disease (AD) and their families must confront two fundamental truths. First, AD is a uniformly progressive disease that ultimately results in debilitating cognitive impairment. Second, although there is now evidence that some medications may produce transient improvement or
Why are developers, in many cases, unable to identify user problems, even when the information is ready and available? How do such miscommunication situations actually emerge and how could research and information technology help developers and users to overcome this problem? To tackle these questio